ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Medical Oncology

Top Medical Oncology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SABAH AL-ATTAR M.D

Medical Oncology

7,617

$463K

210
165 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

21%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 19%

$61
Average prescription price

Avg: $424

HERBERT MALINOFF MD

Medical Oncology

2,371

$453K

252
100 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

71%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 19%

$191
Average prescription price

Avg: $424

KATHRYN ALGUIRE M.D.

Medical Oncology

1,996

$1.16M

316
237 are 65+

19%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$582
Average prescription price

Avg: $424

PAUL PORTER M.D.

Medical Oncology

1,358

$769K

193
158 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$567
Average prescription price

Avg: $424

LAURA BIERNAT M.D.

Medical Oncology

1,321

$470K

195
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 19%

$356
Average prescription price

Avg: $424

MARK KAMINSKI MD

Medical Oncology

1,297

$939K

179
155 are 65+

8%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 19%

$724
Average prescription price

Avg: $424

SAVITHA BALARAMAN MD

Medical Oncology

1,233

$821K

187
143 are 65+

12%
patients receiving schedule two controlled substances

Avg: 12%

17%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$666
Average prescription price

Avg: $424

GLEN HEGGIE MD

Medical Oncology

1,126

$407K

179
130 are 65+

23%
patients receiving schedule two controlled substances

Avg: 12%

23%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$361
Average prescription price

Avg: $424

GUSTAVO MOREL MD

Medical Oncology

1,103

$379K

166
131 are 65+

17%
patients receiving schedule two controlled substances

Avg: 12%

19%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 19%

$344
Average prescription price

Avg: $424

AMY BOLMER D.O.

Medical Oncology

1,093

$445K

109
77 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$407
Average prescription price

Avg: $424

MOHAMMED OGAILY M.D.

Medical Oncology

1,086

$731K

153
118 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

14%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$674
Average prescription price

Avg: $424

JOY WISSER PAC

Medical Oncology

1,029

$75.1K

209
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

22%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 19%

$73
Average prescription price

Avg: $424

SHANTI THOMAS M.D.

Medical Oncology

950

$688K

174
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$725
Average prescription price

Avg: $424

JUSTIN KLAMERUS M.D.

Medical Oncology

939

$579K

148
118 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

17%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 19%

$617
Average prescription price

Avg: $424

THOMAS DOYLE M.D.

Medical Oncology

924

$346K

152
125 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

17%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 19%

$375
Average prescription price

Avg: $424

MAYUR PATEL M.D.

Medical Oncology

919

$460K

216
164 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 19%

$500
Average prescription price

Avg: $424

RICHARD ZEKMAN DO

Medical Oncology

889

$518K

133
105 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

20%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$582
Average prescription price

Avg: $424

ANIBAL DRELICHMAN MD

Medical Oncology

874

$175K

129
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

19%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 19%

$200
Average prescription price

Avg: $424

JUDITH RAMSDELL M.D.

Medical Oncology

864

$63.6K

84
67 are 65+

14%
patients receiving schedule two controlled substances

Avg: 12%

24%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 19%

$74
Average prescription price

Avg: $424

BASSEL EL-RAYES MD

Medical Oncology

844

$396K

146
100 are 65+

43%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 19%

$469
Average prescription price

Avg: $424

EUGENE AGNONE M.D.

Medical Oncology

807

$107K

182
164 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 19%

$133
Average prescription price

Avg: $424

PARVEZ KHAN M.D.

Medical Oncology

774

$253K

173
133 are 65+

9%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 19%

$326
Average prescription price

Avg: $424

MARK ZALUPSKI MD

Medical Oncology

752

$395K

92
76 are 65+

37%
patients receiving schedule two controlled substances

Avg: 12%

38%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 19%

$526
Average prescription price

Avg: $424

VINCENT SHEN M.D.

Medical Oncology

740

$1.02M

125
99 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 19%

$1380
Average prescription price

Avg: $424

MICHAEL BERKOVIC DO

Medical Oncology

734

$253K

142
113 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 19%

$345
Average prescription price

Avg: $424

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank